Canada - anglais - Health Canada

teva canada limited - rosiglitazone (rosiglitazone maleate) - tablet - 8mg - rosiglitazone (rosiglitazone maleate) 8mg - thiazolidinediones

Canada - anglais - Health Canada

pharmaris canada inc - metformin hydrochloride - tablet - 1000mg - metformin hydrochloride 1000mg

Irlande - anglais - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - sitagliptin; metformin hydrochloride - film-coated tablet - 50 mg/1000 milligram(s) - metformin and sitagliptin

Irlande - anglais - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - sitagliptin; metformin hydrochloride - film-coated tablet - 50 mg/850 milligram(s) - metformin and sitagliptin

États-Unis - anglais - NLM (National Library of Medicine)

physicians total care, inc. - rosiglitazone maleate (unii: kx2339dp44) (rosiglitazone - unii:05v02f2kdg) - rosiglitazone maleate 2 mg - avandia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. - due to its mechanism of action, avandia is active only in the presence of endogenous insulin. therefore, avandia should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. - the coadministration of avandia and insulin is not recommended. - the use of avandia with nitrates is not recommended. initiation of avandia in patients with established new york heart association (nyha) class iii or iv heart failure is contraindicated [see boxed warning] . pregnancy category c. all pregnancies have a background risk of birth defects, loss, or other adverse outcome regardless of drug exposure. this background risk is increased in pregnancies complicated by hyperglycemia and may be decreased with good metabolic control. it is essential for patients with diabetes or history of gestational diabetes to maintain good metabolic control before con

Irlande - anglais - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - sitagliptin; metformin hydrochloride - film-coated tablet - 50 mg/1000 milligram(s) - metformin and sitagliptin

Irlande - anglais - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - sitagliptin; metformin hydrochloride - film-coated tablet - 50 mg/850 milligram(s) - metformin and sitagliptin

Irlande - anglais - HPRA (Health Products Regulatory Authority)

rowex ltd - sitagliptin hydrochloride; metformin hydrochloride - film-coated tablet - 50/1000 milligram(s) - metformin and sitagliptin

Irlande - anglais - HPRA (Health Products Regulatory Authority)

rowex ltd - sitagliptin hydrochloride; metformin hydrochloride - film-coated tablet - 50/850 milligram(s) - metformin and sitagliptin

Irlande - anglais - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - sitagliptin hydrochloride monohydrate; metformin hydrochloride - film-coated tablet - metformin and sitagliptin